Clinical Trials in San Diego

Showing 2301-2320 of 14,679 trials

Randomized Withdrawal Study in Patients With Schizophrenia

NCT06961968

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.

Schizophrenia

Vanda Pharmaceuticals400 participantsStarted May 2025

Rogers, Arkansas, United States • Costa Mesa, California, United States • Lemon Grove, California, United States +19 more locations

Active Not RecruitingPhase 2< 1 mile

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

NCT05690386

A 104 week dose finding open label trial followed by an optional 78 week open label extension of lonapegsomatropin, a long-acting growth hormone product, administered once-a-week versus daily somatropin product in prepubertal individuals with Turner syndrome. Approximately 48 individuals (12 individuals per arm) will be randomized to receive one of three doses of lonapegsomatropin or a daily injection of somatropin. This is a trial that will be conducted in the United States.

Turner Syndrome

Ascendis Pharma Endocrinology Division A/S48 participantsStarted Feb 2023

Palo Alto, California, United States • San Diego, California, United States • Aurora, Colorado, United States +16 more locations

Randomized Withdrawal Study in Patients With Schizophrenia

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Find Trials by Condition in San Diego

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

ASSESS ALL ALS Study

STimulation to Activate RespIration

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

IC-8 Apthera IOL New Enrollment Post Approval Study

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients